453
Views
26
CrossRef citations to date
0
Altmetric
Original Research

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

, MD PhD, , MD, , MD, , MD, , MD, , MD, , BD PhD, , MD, , MD, , MD & , MD PhD show all
Pages 1971-1982 | Published online: 23 Jun 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Inger Smith, Emily Hardy, Stephen Mitchell & Sarah Batson. (2022) Semaglutide 2.4 Mg for the Management of Overweight and Obesity: Systematic Literature Review and Meta-Analysis. Diabetes, Metabolic Syndrome and Obesity 15, pages 3961-3987.
Read now
Muqing Gu, Xiangyan Ruan, Yanqiu Li, Tianhe Li, Chenghong Yin & Alfred O. Mueck. (2022) Effect on the cardiovascular independent risk factor lipoprotein(a) in overweight or obese PCOS patients with ethinyl-estradiol/drospirenone alone or plus orlistat. Gynecological Endocrinology 38:7, pages 598-602.
Read now
Awadhesh Kumar Singh & Ritu Singh. (2020) Pharmacotherapy in obesity: a systematic review and meta-analysis of randomized controlled trials of anti-obesity drugs. Expert Review of Clinical Pharmacology 13:1, pages 53-64.
Read now
Robin L. Black, Ashley M. Higbea, Courtney Duval & Lisa M. Chastain. (2016) Pharmacological management of obesity in patients with type 2 diabetes. Expert Review of Endocrinology & Metabolism 11:5, pages 415-423.
Read now
Ellen E Ladenheim. (2015) Liraglutide and obesity: a review of the data so far. Drug Design, Development and Therapy 9, pages 1867-1875.
Read now
Giuseppe Derosa & Pamela Maffioli. (2012) Anti-obesity drugs: a review about their effects and their safety. Expert Opinion on Drug Safety 11:3, pages 459-471.
Read now
Niki Katsiki, Dimitri P Mikhailidis, Anna Gotzamani-Psarrakou, John G Yovos & Dimitrios Karamitsos. (2011) Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus. Expert Opinion on Therapeutic Targets 15:4, pages 401-420.
Read now

Articles from other publishers (19)

Nisrine I. Kawa & Souheil W. Adra. 2023. Inflammation and Obesity. Inflammation and Obesity 233 262 .
Eduardo Grunvald, Raj Shah, Ruben Hernaez, Apoorva Krishna Chandar, Octavia Pickett-Blakely, Levi M. Teigen, Tasma Harindhanavudhi, Shahnaz Sultan, Siddharth Singh & Perica Davitkov. (2022) AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology 163:5, pages 1198-1225.
Crossref
Mobina Aghajani, Saleh Rahmati-Ahmadabad, Farhad Zamani, Behrouz Ghanbari & Mohammad-Ali Azarbayjani. (2021) The effects of high-intensity interval training and orlistat on selected adipokines and cytokines in obese womenAuswirkungen von Hochintensitätsintervalltraining und Orlistat auf ausgewählte Adipokine und Zytokine bei adipösen Frauen. German Journal of Exercise and Sport Research 52:1, pages 87-96.
Crossref
Chu Lin, Xiaoling Cai, Wenjia Yang, Fang Lv, Lin Nie & Linong Ji. (2020) The Body Weight Alteration and Incidence of Neoplasm in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Frontiers in Endocrinology 11.
Crossref
Anna Casu, Anika Bilal & Richard E. Pratley. (2020) Pharmacological therapies to address obesity in type 1 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity 27:4, pages 194-206.
Crossref
Kazim Sahin, Cemal Orhan, Osman Kucuk, Nurhan Sahin, Mehmet Tuzcu, Besir Er, Shane Durkee & Aouatef Bellamine. (2020) A Dose-Dependent Effect of Carnipure® Tartrate Supplementation on Endurance Capacity, Recovery, and Body Composition in an Exercise Rat Model. Nutrients 12:5, pages 1519.
Crossref
Minyi Lee, Brianna N. Lauren, Tiannan Zhan, Jin Choi, Matthew Klebanoff, Barham Abu Dayyeh, Elsie M. Taveras, Kathleen Corey, Lee Kaplan & Chin Hur. (2020) The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity. Obesity Science & Practice 6:2, pages 162-170.
Crossref
David W. Hudgel, Sanjay R. Patel, Amy M. Ahasic, Susan J. Bartlett, Daniel H. Bessesen, Melisa A. Coaker, P. Michelle Fiander, Ronald R. Grunstein, Indira Gurubhagavatula, Vishesh K. Kapur, Christopher J. Lettieri, Matthew T. Naughton, Robert L. Owens, Jean-Louis D. Pepin, Henri Tuomilehto & Kevin C. Wilson. (2018) The Role of Weight Management in the Treatment of Adult Obstructive Sleep Apnea. An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine 198:6, pages e70-e87.
Crossref
Ali Nazary-vannani, Ehsan Ghaedi, Seyed Mohammad Mousavi, Alireza Teymouri, Jamal Rahmani & Hamed Kord Varkaneh. (2018) The effect of l-carnitine supplementation on serum leptin concentrations: a systematic review and meta-analysis of randomized controlled trials. Endocrine 60:3, pages 386-394.
Crossref
F. B. Del Vecchio, V. S. Coswig & L. M. Galliano. (2017) Comment on ‘The effect of ( l -)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials’ . Obesity Reviews 18:2, pages 277-278.
Crossref
M. Pooyandjoo, M. Nouhi, S. Shab-Bidar, K. Djafarian & A. Olyaeemanesh. (2016) The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials. Obesity Reviews 17:10, pages 970-976.
Crossref
Giuseppe Derosa, Pamela Maffioli & Amirhossein Sahebkar. (2016) Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis. British Journal of Clinical Pharmacology 81:5, pages 819-834.
Crossref
Vladimír Pavlík, Jana Fajfrová, Jan M. Horáček, Václav Šafka, Pavla Krutišová, Miroslav Urban, Peter Urban, Jana Gazdačková & Petr Navrátil. (2016) ORLISTAT AND PHENTERMINE IN WEIGHT LOSS IN SELECTED CZECH POPULATION. Military Medical Science Letters 85:1, pages 13-18.
Crossref
Kieren J. Mather & Ronald B. Goldberg. (2014) Clinical use of adiponectin as a marker of metabolic dysregulation. Best Practice & Research Clinical Endocrinology & Metabolism 28:1, pages 107-117.
Crossref
Giuseppe Derosa & Pamela Maffioli. 2014. Integrative Weight Management. Integrative Weight Management 261 277 .
Vladimír Pavlík, Jana Fajfrová & Eva Drahokoupilová. (2013) The effect of orlistat on body weight in obese Czech adults. Open Medicine 8:5, pages 553-557.
Crossref
Marietta Charakida, Dimitris Tousoulis & Nicholas Finer. (2013) Drug treatment of obesity in the cardiovascular patient. Current Opinion in Cardiology 28:5, pages 584-591.
Crossref
G. Derosa, A. F. G. Cicero, A. D’Angelo, E. Fogari & P. Maffioli. (2012) Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes. Journal of Clinical Pharmacy and Therapeutics 37:2, pages 187-195.
Crossref
Giuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, Angela D’Angelo, Elena Fogari, Ilaria Palumbo, Sabrina Randazzo & Arrigo F.G. Cicero. (2011) Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. Fundamental & Clinical Pharmacology 25:5, pages 642-651.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.